P2RY2 has an important function in the regulation of blood pressure by activating adenosine triphosphate (ATP). The aim of this study was to investigate the association between the human P2RY2 gene and essential hypertension (EH) through a haplotype-based casecontrol study that included two gender groups. The 273 EH patients and 255 age-matched controls were genotyped for five single-nucleotide polymorphisms (SNPs) of the human P2RY2 gene (rs4944831, rs1783596, rs4944832, rs4382936 and rs10898909). Data were analysed for men and women separately and then as a combined total group. For the total and the men only groups, the genotype distribution of the T allele of rs4944831 and the recessive model (GG vs TG þ TT) of rs4944831 differed significantly between the EH patients and controls (P ¼ 0.028 and 0.019; P ¼ 0.009 and 0.008, respectively). Logistic regression showed that for the total and men groups, the TG þ TT genotype of rs4944831 was more prevalent in EH patients than in the controls (P ¼ 0.026 and 0.011, respectively). For men, the overall distribution of the haplotype (SNP2-SNP4-SNP5) was significantly different between the EH patients and the controls (P ¼ 0.006). As compared with controls, the frequency of the T-A-G haplotype was significantly higher, whereas the T-C-G haplotype was significantly lower for the EH patients (P ¼ 0.001 and 0.014, respectively). In conclusion, the present results indicate that rs4944831 and the T-A-G haplotype of the human P2RY2 gene might be genetic markers for EH in Japanese men.
Introduction
Essential hypertension (EH) is most likely a polygenic disorder that results from the inheritance of a number of susceptibility genes and involves environmental, demographic, vascular and neuroendocrine factors. 1 More than 50 genes have been examined in association studies with hypertension, with this number continuing to grow. A number of polymorphisms in the candidate genes have been associated with differences in blood pressure (BP) level in certain populations and have been of considerable help in understanding the genetics of hypertension. 2 Development of extensive collections of single-nucleotide polymorphisms (SNPs) raises the possibility that these SNPs can be used as markers in genome-wide association mapping studies to identify hypertension susceptibility loci.
Purinergic receptors have been classified as P1 and P2 receptors. At least eight P2 receptor subtypes (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13 and P2Y14) have been identified 3 in pharmacological and molecular cloning studies. The P2Y2 receptor, which is also referred to as P2RY2 (official name: purinergic receptor P2Y, G-protein coupled, 2), belongs to the family of G-protein coupled receptors. G-proteins mediate the intracellular effects of many vasoactive and proliferative stimuli. Recently, G-protein signalling was found to be enhanced in cultured cells of various hypertensive subjects. 4 Thus, the purinergic system may be similar in importance as the sympathetic and reninangiotensin-aldosterone (RAA) systems are for cardiovascular regulation and pathophysiology. P2RY2 is expressed in different regions of the kidney, which includes the vasculature and the glomerulus, in addition to the tubular epithelia and collecting duct system. 5 The epithelial sodium channel (ENaC) in the renal collecting duct is critically involved in the regulation of renal Na þ reabsorption and K þ excretion, as well as in the genetic forms of arterial hypertension. 6 Lehrmann et al. 7 found that P2PY2 might mediate the adenosine triphosphate (ATP) responses involved in the inhibition of the ENaC-mediated Na þ reabsorption. Furthermore, a variety of experimental approaches have provided evidence that local ATP release and P2RY2 stimulation may inhibit water reabsorption in the collecting duct. 8 Previous studies in mice have identified important functions for P2RY2 in a variety of processes, including nucleotide-regulated Ca 2 þ signalling in lung fibroblasts and airway epithelial cells, 9 nucleotide-stimulated Cl À secretion in the trachea and gallbladder, 10 neuronal growth, 11 stimulation of K þ secretion in the colon 12 and neutrophil chemotaxis. 13 In 2007, Rieg et al. 14 reported that saltresistant hypertension occurs in the P2Y2 receptor (mice homologue of the human P2RY2 gene) knockout mice because the baroreceptor response to variations in salt intake remains intact. Furthermore, the study showed that the P2Y2 receptor gene has an important function in the regulation of both the BP and the renal reabsorption of Na þ and fluid in the animal model.
To the best of our knowledge, there have been no previous studies on the association between the human P2RY2 gene and EH. Therefore, the aim of this study was to investigate the association between the human P2RY2 gene and EH in Japanese subjects through a haplotype-based case-control study that used SNPs.
Materials and methods

Subjects
Subjects diagnosed with EH were recruited at Nihon University Itabashi Hospital and other neighbouring hospitals in Tokyo from 1993 to 2008. We enrolled 273 EH patients in this study, with a male/female (m/f) ratio of 1.97. EH was diagnosed based on the following criteria: seated systolic BP (SBP)4 160 mm Hg or diastolic BP (DBP)4100 mm Hg on three occasions within 2 months after the first BP reading. None of the EH patients were receiving antihypertensive medication. Patients diagnosed with secondary hypertension were excluded. A total of 255 normotensive age-matched healthy individuals (m/f ratio ¼ 1.66) were enrolled as controls. None of the controls had a family history of hypertension, and all had an SBP o130 mm Hg and a DBP o85 mm Hg. Informed consent was obtained from each subject in accordance with the protocol approved by the Human Studies Committee of Nihon University. 15 
Genotyping
The human P2RY2 gene is located at chromosome 11q13. 5 According to the above criterion, we selected rs4944831 (C-12034890-10, registration number by Applied Biosystems Inc., Foster City, CA, USA), rs1783596 (C-8893575-10), rs4944832 (C-27987464-10), rs4382936 (C-1830488-20) and rs10898909 (C-1830487-10) for this gene (Figure 1 ). SNP1 was located in intron 1, whereas SNP2 was located in the coding regions of exon 3 of this gene. SNP3, SNP4 and SNP5 were located in the 3 0 -flanking region of the gene. Blood samples were collected from all participants, and genomic DNA was extracted from the peripheral blood leucocytes by phenol and chloroform extraction. 16 Genotyping was performed using the TaqMan SNP Genotyping Assay (Applied Biosystems Inc.). The TaqMan SNP Genotyping Assays were performed using the method of Taq amplification. 17 In the 5 0 nuclease assay, discrimination occurs during the polymerase chain reaction (PCR) because of allelespecific fluorogenic probes that, when hybridized to the template, are cleaved by the 5 0 nuclease activity of the Taq polymerase. The probes contain a 3 0 minor groove-binding group that hybridizes to single-stranded targets with greater sequence specificity than ordinary DNA probes. This reduces nonspecific probe hybridization, and results in low background fluorescence in the 5 0 nuclease PCR assay (TaqMan; Applied Biosystems Inc.). Cleavage results in increased emission of a reporter dye. Each 5 0 nuclease assay requires two unlabelled PCR primers and two allele-specific probes. Each probe is labelled with two reporter dyes at the 5 0 end. In this study, VIC and FAM were used as the reporter dyes. The primers and probes used in the TaqMan SNP Genotyping Assays (Applied Biosystems Inc.) were chosen based on information available on the Applied Biosystems Inc. website (http://myscience. appliedbiosystems.com).
PCR amplification was performed using 2.5 ml of TaqMan Each 96-well plate contained 80 DNA samples of an unknown genotype and four reaction mixtures containing reagents but no DNA (control). The control samples without DNA are a necessary part of the Sequence Detection System (SDS) 7700 signal processing, as outlined in the TaqMan Allelic Discrimination Guide (Applied Biosystems Inc.). The plates were read on the SDS 7700 instrument with the end-point analysis mode of the SDS version 1.6.3 software package (Applied Biosystems Inc.). The genotypes were determined visually based on the dye-component fluorescent emission data depicted in the X-Y scatter plot of the SDS software. The genotypes were also determined automatically by the signal processing algorithms of the software. The results of each scoring method were saved in two separate output files for later comparison. 18 
Biochemical analysis
We measured the plasma concentration of creatinine and uric acid, using standard methods used by the Clinical Laboratory Department of Nihon University Hospital. 19 
Statistical analysis
All continuous variables were expressed as mean ± s.d. Differences in continuous variables between EH patients and control individuals were analysed using the Mann-Whitney U-test. Differences in categorical variables were analysed using a Fisher's exact test. Hardy-Weinberg equilibrium was assessed by w 2 analysis. Differences in distributions of genotypes and alleles between EH patients and control individuals were analysed using Fisher's exact test. On the basis of the genotype data of the genetic variations, we performed linkage disequilibrium analysis and haplotype-based casecontrol analysis, using the expectation maximization algorithm 20 and the software SNPAlyze version 3.2 (Dynacom Co, Ltd, Yokohama, Japan). 21 The pairwise linkage disequilibrium analysis was performed using five SNPs. We used |D 0 | values 40.5 to assign SNP locations to one haplotype block. SNPs with an r 2 value o0.5 were selected as tagged. In the haplotype-based case-control analysis, the frequency distribution of the haplotypes was calculated by a w 2 analysis. In addition, logistic regression analysis was performed to assess the contribution of the major risk factors. Statistical significance was established at P-values o0.05. Statistical analyses were performed using SPSS software for Windows (version 12; SPSS Inc., Chicago, IL, USA).
Results and discussion Table 1 shows the clinical characteristics of the study participants. For the combined total group, and separated men and women only groups, the following values were significantly higher for the EH patients as compared with the controls: body mass index, SBP, DBP and the incidence of drinking and smoking. For both the total and the men only groups, pulse rate, the incidence of hyperlipidemia and the incidence of diabetes were significantly higher for EH patients as compared with the controls. For men, the uric acid plasma concentration was significantly higher for the EH patients as compared with the controls. There were no significant differences noted for age and serum creatinine between the EH patients and the controls. Table 2 shows the distribution of the genotypes and alleles for the five SNPs. For each SNP, the genotype distributions were not significantly different from the Hardy-Weinberg equilibrium values (data not shown) in the controls. For both the total and men only groups, the genotype distribution of rs4944831 differed significantly between the EH patients and the controls (P ¼ 0.028 and 0.019, respectively). The distribution of the recessive model of rs4944831 (GG vs TG þ TT) also differed significantly for the total and men only groups between the EH patients and the controls (P ¼ 0.009 and 0.008, respectively). Dominant and recessive models were defined by the frequencies noted among the total control individuals. There were no significant differences in overall distributions of the frequencies in the alleles for any of the five SNPs between the EH and control groups. Table 3 shows the results of the logistic regression analysis. Logistic regression was performed using the following parameters: TG þ TT genotype of rs4944831, body mass index, pulse rate, with or without hyperlipidemia, diabetes mellitus and smoking or drinking. The results indicated that the TG þ TT genotype of rs4944831 was significantly higher in the EH patients vs the control individuals for the total and men only groups (P ¼ 0.026 and 0.011, respectively). At the same time, for the total and men only groups, the body mass index, pulse rate and the use of alcohol still differed significantly between the EH patients and controls. There was also a significant difference noted for smoking between the EH patients and the controls in the men only group. Table 4 shows patterns of linkage disequilibrium in control individuals for the P2RY2 gene, with their |D 0 | and r 2 values. Out of the five SNPs, four (SNP2, SNP3, SNP4 and SNP5) had |D 0 | values that were beyond 0.5, which means they were all located within one haplotype block. SNP1 was the only exception, as the results indicated that it was located in a different haplotype block. As the r 2 values for SNP2-SNP3 were 40.5, simply having at least one SNP made it possible to perform the haplotype-based case-control study. Therefore, given that the minor allele frequency of SNP2 was larger than that observed for SNP3, we constructed the haplotypes using SNP2, SNP4 and SNP5.
For the haplotype-based case-control study, there were four combinations, which included SNP2-SNP4, SNP2-SNP5, SNP4-SNP5 and SNP2-SNP4-SNP5 (Table 5 ). For men, the overall distribution of the haplotype established by SNP2, SNP4 and SNP5 was significantly different between the EH patients and the controls (P ¼ 0.006). For the total group, the frequency of the T-C-G haplotype (SNP2-SNP4-SNP5) was significantly lower for the EH patients as compared with the controls (P ¼ 0.020). For men, both the frequency of the T-A haplotype (SNP2-SNP4) and T-A-G haplotype (SNP2-SNP4-SNP5) were significantly higher for the EH patients as compared with the controls (P ¼ 0.043 and 0.014, respectively). In contrast, the frequency of the T-C-G haplotype (SNP2-SNP4-SNP5) was significantly lower for the EH patients as compared with the controls (P ¼ 0.001).
In 1994, Parr et al. 22 were the first to report the sequence and functional expression of the cDNA cloned from the airway epithelial cells that encoded P2RY2, which is a protein with properties of the P2U nucleotide receptor. In 1996, Dasari et al. 23 were the first to perform PCR analysis of the humanrodent hybrid cell line DNAs, and this led to the mapping of the human P2RY2 gene to chromosome 11q13.5-q14.1. P2RY2 belongs to the family of the Gprotein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity. P2RY2 may participate in various types of physiological responses, including secretion, membrane potential, cell proliferation, platelet aggregation, neurotransmission, cardiac function and muscle contraction 24 by activating ATP. ATP is released from cells such as the platelets and co-released with neurotransmitter granules from the autocrine nerves by exocytosis. 25 Extracellular ATP binds to P2RY2, with the combination activating phospholipase C and phosphatidylinositol hydrolysis. This can then generate diacylglycerol and inositol 1,4,5-triphosphate, which stimulate protein kinase C and cytosolic calcium (Ca 2 þ ) mobilization, respectively. 26 Guyton 27 proposed that all types of hypertension have impaired renal Na þ excretion and thus, a rise in the BP stabilizes the Na þ homeostasis by increasing renal Na þ excretion through pressure natriuresis. The mechanism for the regulation of ENaC by P2RY2 proposed by Kunzelmann et al. 28 states that under resting conditions, the inner leaflet of the lipid bilayer contains a high concentration of 14 indicated in a recent animal study that the P2RY2 gene was a candidate causative gene of hypertension. The study showed that there was a greater reabsorption of water in the collecting duct and that Na þ through ENaC could potentially cause an initial induction of isotonic hyperreabsorption in P2Y2 receptor knockout mice, resulting in a salt-resistant hypertension. The aim of our current animal study was to assess the association between the P2RY2 gene and EH by using a haplotype-based case-control study. Our results showed that the genotypic distribution of the T allele of rs4944831 and the recessive model (GG vs TG þ TT) of rs4944831 significantly differed between the EH patients and the controls for both the total and men only groups. The present results also indicated that the risk of EH is increased in subjects with the T allele of rs4944831 and that the recessive model of rs4944831 is associated with EH in Japanese men. The logistic regression analyses indicated that for both the total and the men only groups, the TG þ TT genotype distribution of rs4944831 was significantly different between the EH patients and the controls. This suggests that the SNP is most probably associated with gender-specific hypertension. We also showed that body mass index, pulse rate and alcohol consumption were risk factors associated with EH for both the total and men only groups. This study also showed that smoking was a risk factor of EH, especially in men. Abbreviation: EH, essential hypertension. Haplotypes were estimated using software SNPAlyze (version 3.2; Dynacom Co., Ltd., Yokohama, Japan). P-value was calculated by w 2 analysis. *Po0.05.
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